Search

Your search keyword '"Camilla Guerrero"' showing total 5 results
Start Over Author "Camilla Guerrero"
5 results on '"Camilla Guerrero"'

1. Supplementary Table from Circulating Tumor and Immune Cells for Minimally Invasive Risk Stratification of Smoldering Multiple Myeloma

Author

Bruno Paiva, Jesus F. San-Miguel, Aldo M. Roccaro, Hervé Avet-Loiseau, Hartmut Goldschmidt, Alberto Orfao, Juan Flores-Montero, Maria-Victoria Mateos, Noemi Puig, Pablo Rios, Maria Sarasa, Luis Palomera, José-Ángel Hernández-Rivas, Javier de la Rubia, Albert Oriol, Maialen Sirvent, Valentin Cabañas, Adrian Alegre, Maria Casanova, Antoni Garcia-Guiñon, Heinz Ludwig, Felipe De Arriba, Clara Gomez, Helena Vitoria, Catarina Geraldes, Artur Paiva, Rebeca Iglesias, Fernando Solano, Joaquin Martinez-Lopez, Roman Hájek, Enrique M. Ocio, Maria-Elena Cabezudo, Joan Bargay, Felipe Prosper, Luis-Esteban Tamariz-Amador, Aitziber Lopez, Juan-Jose Garces, Cirino Botta, Camilla Guerrero, Esperanza Martín-Sánchez, Catarina Maia, Cristina Perez, Cristina Moreno, Sara Rodriguez, Alessandra Tucci, Viviana Giustini, Marco Chiarini, Antonio Sacco, Francois Vergez, Jill Corre, Anna Luise Grab, Elias K. Mai, Niels Weinhold, Marc Raab, Tomáš Jelínek, Albert Perez-Montaña, Evangelos Terpos, David Žihala, and Rosalinda Termini

Abstract

Supplementary Table from Circulating Tumor and Immune Cells for Minimally Invasive Risk Stratification of Smoldering Multiple Myeloma

Published
2023
Full Text
View/download PDF

2. Supplementary Figure from Circulating Tumor and Immune Cells for Minimally Invasive Risk Stratification of Smoldering Multiple Myeloma

Author

Bruno Paiva, Jesus F. San-Miguel, Aldo M. Roccaro, Hervé Avet-Loiseau, Hartmut Goldschmidt, Alberto Orfao, Juan Flores-Montero, Maria-Victoria Mateos, Noemi Puig, Pablo Rios, Maria Sarasa, Luis Palomera, José-Ángel Hernández-Rivas, Javier de la Rubia, Albert Oriol, Maialen Sirvent, Valentin Cabañas, Adrian Alegre, Maria Casanova, Antoni Garcia-Guiñon, Heinz Ludwig, Felipe De Arriba, Clara Gomez, Helena Vitoria, Catarina Geraldes, Artur Paiva, Rebeca Iglesias, Fernando Solano, Joaquin Martinez-Lopez, Roman Hájek, Enrique M. Ocio, Maria-Elena Cabezudo, Joan Bargay, Felipe Prosper, Luis-Esteban Tamariz-Amador, Aitziber Lopez, Juan-Jose Garces, Cirino Botta, Camilla Guerrero, Esperanza Martín-Sánchez, Catarina Maia, Cristina Perez, Cristina Moreno, Sara Rodriguez, Alessandra Tucci, Viviana Giustini, Marco Chiarini, Antonio Sacco, Francois Vergez, Jill Corre, Anna Luise Grab, Elias K. Mai, Niels Weinhold, Marc Raab, Tomáš Jelínek, Albert Perez-Montaña, Evangelos Terpos, David Žihala, and Rosalinda Termini

Abstract

Supplementary Figure from Circulating Tumor and Immune Cells for Minimally Invasive Risk Stratification of Smoldering Multiple Myeloma

Published
2023
Full Text
View/download PDF

3. Supplementary Data from Circulating Tumor and Immune Cells for Minimally Invasive Risk Stratification of Smoldering Multiple Myeloma

Author

Bruno Paiva, Jesus F. San-Miguel, Aldo M. Roccaro, Hervé Avet-Loiseau, Hartmut Goldschmidt, Alberto Orfao, Juan Flores-Montero, Maria-Victoria Mateos, Noemi Puig, Pablo Rios, Maria Sarasa, Luis Palomera, José-Ángel Hernández-Rivas, Javier de la Rubia, Albert Oriol, Maialen Sirvent, Valentin Cabañas, Adrian Alegre, Maria Casanova, Antoni Garcia-Guiñon, Heinz Ludwig, Felipe De Arriba, Clara Gomez, Helena Vitoria, Catarina Geraldes, Artur Paiva, Rebeca Iglesias, Fernando Solano, Joaquin Martinez-Lopez, Roman Hájek, Enrique M. Ocio, Maria-Elena Cabezudo, Joan Bargay, Felipe Prosper, Luis-Esteban Tamariz-Amador, Aitziber Lopez, Juan-Jose Garces, Cirino Botta, Camilla Guerrero, Esperanza Martín-Sánchez, Catarina Maia, Cristina Perez, Cristina Moreno, Sara Rodriguez, Alessandra Tucci, Viviana Giustini, Marco Chiarini, Antonio Sacco, Francois Vergez, Jill Corre, Anna Luise Grab, Elias K. Mai, Niels Weinhold, Marc Raab, Tomáš Jelínek, Albert Perez-Montaña, Evangelos Terpos, David Žihala, and Rosalinda Termini

Abstract

Supplementary Data from Circulating Tumor and Immune Cells for Minimally Invasive Risk Stratification of Smoldering Multiple Myeloma

Published
2023
Full Text
View/download PDF

4. Data from Circulating Tumor and Immune Cells for Minimally Invasive Risk Stratification of Smoldering Multiple Myeloma

Author

Bruno Paiva, Jesus F. San-Miguel, Aldo M. Roccaro, Hervé Avet-Loiseau, Hartmut Goldschmidt, Alberto Orfao, Juan Flores-Montero, Maria-Victoria Mateos, Noemi Puig, Pablo Rios, Maria Sarasa, Luis Palomera, José-Ángel Hernández-Rivas, Javier de la Rubia, Albert Oriol, Maialen Sirvent, Valentin Cabañas, Adrian Alegre, Maria Casanova, Antoni Garcia-Guiñon, Heinz Ludwig, Felipe De Arriba, Clara Gomez, Helena Vitoria, Catarina Geraldes, Artur Paiva, Rebeca Iglesias, Fernando Solano, Joaquin Martinez-Lopez, Roman Hájek, Enrique M. Ocio, Maria-Elena Cabezudo, Joan Bargay, Felipe Prosper, Luis-Esteban Tamariz-Amador, Aitziber Lopez, Juan-Jose Garces, Cirino Botta, Camilla Guerrero, Esperanza Martín-Sánchez, Catarina Maia, Cristina Perez, Cristina Moreno, Sara Rodriguez, Alessandra Tucci, Viviana Giustini, Marco Chiarini, Antonio Sacco, Francois Vergez, Jill Corre, Anna Luise Grab, Elias K. Mai, Niels Weinhold, Marc Raab, Tomáš Jelínek, Albert Perez-Montaña, Evangelos Terpos, David Žihala, and Rosalinda Termini

Abstract

Purpose:Early intervention in smoldering multiple myeloma (SMM) requires optimal risk stratification to avoid under- and overtreatment. We hypothesized that replacing bone marrow (BM) plasma cells (PC) for circulating tumor cells (CTC), and adding immune biomarkers in peripheral blood (PB) for the identification of patients at risk of progression due to lost immune surveillance, could improve the International Myeloma Working Group 20/2/20 model.Experimental Design:We report the outcomes of 150 patients with SMM enrolled in the iMMunocell study, in which serial assessment of tumor and immune cells in PB was performed every 6 months for a period of 3 years since enrollment.Results:Patients with >0.015% versus ≤0.015% CTCs at baseline had a median time-to-progression of 17 months versus not reached (HR, 4.9; P 20% BM PCs had no prognostic value in a multivariate analysis that included serum free light-chain ratio >20, >2 g/dL M-protein, and >0.015% CTCs. The 20/2/20 and 20/2/0.015 models yielded similar risk stratification (C-index of 0.76 and 0.78). The combination of the 20/2/0.015 model with an immune risk score based on the percentages of SLAN+ and SLAN− nonclassical monocytes, CD69+HLADR+ cytotoxic NK cells, and CD4+CXCR3+ stem central memory T cells, allowed patient’ stratification into low, intermediate-low, intermediate-high, and high-risk disease with 0%, 20%, 39%, and 73% rates of progression at 2 years.Conclusions:This study showed that CTCs outperform BM PCs for assessing tumor burden. Additional analysis in larger series are needed to define a consensus cutoff of CTCs for minimally invasive stratification of SMM.

Published
2023
Full Text
View/download PDF

5. The Role of the Interdisciplinary Team in Subacute Rehabilitation for Central Pontine Myelinolysis

Author

Camilla Guerrero, Maybel Kyin, Katelyn Fuller, Marie Yeseta, and Cathelyn Timple

Subjects
Adult, 030506 rehabilitation, medicine.medical_specialty, medicine.medical_treatment, Physical Therapy, Sports Therapy and Rehabilitation, 03 medical and health sciences, 0302 clinical medicine, Physical medicine and rehabilitation, medicine, Humans, Retrospective Studies, Rehabilitation, business.industry, fungi, food and beverages, Recovery of Function, Patient-centered care, Prognosis, medicine.disease, Magnetic Resonance Imaging, Myelinolysis, Central Pontine, Central pontine myelinolysis, Female, Locked-in syndrome, 0305 other medical science, business, 030217 neurology & neurosurgery, Inpatient rehabilitation, Multidisciplinary rehabilitation
Abstract

Background: Central pontine myelinolysis is a rare condition that can result in debilitating symptoms. Recent evidence suggests a shift in hypothesized prognosis for individuals with this diagnosis...

Published
2019
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results